<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; XOMA Limited</title>
	<atom:link href="http://www.stockbloghub.com/tag/xoma-limited/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(XOMA) XOMA Earnings Report Tops Consensus Estimates</title>
		<link>http://www.stockbloghub.com/2010/03/12/xoma-xoma-earnings-report-tops-consensus-estimates/30534</link>
		<comments>http://www.stockbloghub.com/2010/03/12/xoma-xoma-earnings-report-tops-consensus-estimates/30534#comments</comments>
		<pubDate>Fri, 12 Mar 2010 18:02:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[XOMA]]></category>
		<category><![CDATA[XOMA Limited]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=30534</guid>
		<description><![CDATA[XOMA Ltd. (XOMA) reported fourth-quarter fiscal 2009 earnings of one cent per share, well above the Zacks Consensus Estimate for a loss of 3 cents but below the year-ago earnings of 7 cents. The lower earnings were primarily attributable to the dip in revenues in the fourth quarter of 2009. Quarterly Results Revenue declined approximately 41.5% to $21.6 million from $36.9 million in the year-ago quarter. Revenue from license and collaborative fees came in at $14.5 million, against $14.9 million in the year-ago quarter, down approximately 2.7%. Contract and other revenue dipped approximately 56.7% year-over-year to $ 6.8 million. Royalty income dipped to $0.2 million, against $6.3 million in the year-ago quarter. Research and development expense for the reported quarter stood at $14.7 million, compared to $20.1 million in the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/12/xoma-xoma-earnings-report-tops-consensus-estimates/30534/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

